🤖 AI Summary
Traditional epigenome-wide association studies (EWAS) rely on the magnitude of methylation differences, which often fails to detect weakly differentially methylated yet functionally critical upstream regulatory nodes within gene networks, thereby limiting the resolution of molecular heterogeneity in major depressive disorder (MDD). To address this, this study integrates statistical analysis with machine learning–driven regulatory network inference to construct a two-layer computational framework applied to an MDD methylome dataset (GSE198904, n=206). Moving beyond conventional effect-size–based ranking, this approach incorporates a network-centric perspective to uncover multiple putative regulatory hubs. The findings further support a novel hypothesis of MDD molecular subtypes grounded in regulatory architecture, offering a theoretical foundation for deciphering the mechanistic underpinnings of MDD heterogeneity.
📝 Abstract
Major Depressive Disorder (MDD) is a clinically heterogeneous syndrome with diverse etiological pathways. Traditional Epigenome-Wide Association Studies (EWAS) have successfully identified risk loci based on differential methylation magnitude. As a complementary perspective, effect-size-based ranking alone may not fully capture regulatory nodes that exhibit modest methylation changes but occupy critical upstream positions in biological networks. Here, we report findings and hypotheses from a two-tier computational analysis of DNA methylation data (GSE198904; \(n=206\) ), combining conventional statistical approaches with machine learning-assisted regulatory inference.